Loading organizations...
Loading organizations...
Precision medicine company developing targeted therapeutics.
Avelos Therapeutics has raised $20.5M across 2 funding rounds.
Avelos Therapeutics has raised $20.5M in total across 2 funding rounds.
Avelos Therapeutics has raised $20.5M in total across 2 funding rounds.
Avelos Therapeutics's investors include Mirae Asset Capital, Mirae Asset Venture Investment, QUAD Investment Management, SV Investment, Timefolio Asset Management, UTC Investment.
Avelos Therapeutics has raised $20.5M across 2 funding rounds. Most recently, it raised $12.5M Series B in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 9, 2024 | $12.5M Series B | ||
| Aug 22, 2022 | $8.0M Series A | Mirae Asset Capital, Mirae Asset Venture Investment, QUAD Investment Management, SV Investment, Timefolio Asset Management, UTC Investment |